Director, New Products & Business Development, Solid Tumors

Johnson & Johnson Innovative Medicine•Horsham, PA

2d•Onsite

About The Position

Johnson & Johnson is recruiting a US-based Director, New Products & Business Development, Solid Tumors, located in Horsham, Pennsylvania. This highly visible, cross-functional leadership role is responsible for defining and executing US pre-launch strategy while shaping key global decisions. The Director translates market, clinical, and commercial insights into strategic priorities, influences portfolio investment and development and launch plans through a US lens, and aligns stakeholders around critical outcomes. The role requires sound judgment and the ability to make trade-offs across competing opportunities, and offers enterprise-wide experience in preparation for future senior leadership opportunities. The Director leads US launch readiness and marketing excellence, represents US commercial considerations in global strategy and planning, and provides US input on selected business development opportunities. The role partners with Analytics to develop customer-insight-based forecasts and valuations that inform stage-gate decisions.

Requirements

Bachelor’s degree required.
At least 8 years of business experience, with significant pharmaceutical, biotechnology, or healthcare industry focus.
Experience with in-line launches required.
Strong understanding of US market dynamics, customer insights, competitive strategy, evidence generation, and launch readiness planning.
Experience integrating analytics, forecasting, valuation, and market research into strategic recommendations.
Demonstrated ability to lead cross-functional strategy in a matrixed environment and influence senior stakeholders without direct authority.
Ability to operate in ambiguity, shape strategy early, and move work from insight to decision.
Strong communication skills, including the ability to translate complex asset strategy into clear decisions, trade-offs, and action plans.
Ability to balance enterprise and global inputs with a clear point of view on what is required for US launch success.

Nice To Haves

MBA or advanced degree.
Oncology experience is highly preferred.
Commitment to learning emerging technologies, such as AI, through exploration, iteration, and applying new tools over time.
Skills listed in the posting include alliance formation, business development, business valuations, collaboration, competitive landscape analysis, customer intelligence, due diligence, lateral leadership, market research, negotiation, process improvements, product marketing sales, product strategies, relationship building, strategic change, strategic thinking, tactical planning, and technical credibility.

Responsibilities

Lead cross-functional integrated strategy teams to develop and execute asset and indication strategies and plans for US readiness.
Connect strategy, plans, decisions, and execution into a cohesive launch narrative aligned around shared objectives and outcomes.
Translate complex issues into clear priorities and actions; anticipate risks, opportunities, dependencies, and strategic implications, shape solutions, and drive informed decisions.
Influence and align cross-functional stakeholders around shared objectives, priorities, and outcomes.
Maintain accountability for launch readiness outcomes, address barriers, and ensure critical decisions are made.
Mobilize launch readiness teams around priorities, ensure organizational readiness, and support successful transition to in-line ownership.
Lead US marketing excellence, including positioning, value proposition development, and input into US label planning to align with market needs.
Develop and implement early market-shaping strategies, including unbranded market development, evidence generation, and Key Opinion Leader engagement.
Represent the US point of view to shape global strategy, plans, and execution, ensuring US customer, marketplace, and competitive considerations inform global decisions.
For products progressing through investment governance, ensure US commercial insights inform clinical development plans, competitive vision, Target Product Profile, and value proposition.
For launch preparation, represent the US market in global forums and provide strategic input on global strategy, positioning, trademark and branding, and key pre-launch initiatives.
Partner with Analytics to develop customer-insight-based forecasts and valuations to guide stage-gate decisions.
Lead US input on selected business development opportunities, including competitive landscape assessment, opportunity identification, and prioritization of required product attributes.
Provide a US commercial perspective, including sales and OPEX forecasts, to inform opportunity evaluation and investment decisions.